Publications
- The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N-2-oxide2004 | Faculty of Science
- DNA adduct formation by the anticancer drug ellipticine and its hydroxy derivatives in human breast adenocarcinoma MCF-7 cells2004 | Faculty of Science
- Cytotoxicity if the anticancer drug ellipticine and its hydroxyderivates to MCF-7 human breast cancer cells: study on covalent binding to DNA2003 | Faculty of Science
- Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans2003 | Faculty of Science
- The interaction between the anticancer drug ellipticine and cytochromes P450 dictates its pharmacological efficiencies2003 | Faculty of Science
- Mechanism of DNA adduct formation by anticancer drug ellipticine activated by cytochromes P450 in vitro and in vivo2003 | Faculty of Science
- Anticancer drug ellipticine is oxidized by myeloperoxidase and lactoperoxidase2003 | Faculty of Science
- Rat cytochromes P450 are suitable model enzymes mimicking the metabolic activation of anticancer drug ellipticine in humans2003 | Faculty of Science
- Interaction of anticancer drug ellipticine with cytochromes P4502002 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Anticancer drug ellipticine is oxidized by lactoperoxidase2002 | First Faculty of Medicine, Faculty of Mathematics and Physics
Loading network view...